Posts by Anne-Marie A. Wills, MD, MPH
-
Diet-monitoring App Can Help Slow the Progression of ALS
Patients living with ALS can maintain or improve their body weight more effectively by using a diet monitoring app than by receiving standard care, according to the results of a new clinical trial.
Biography
Anne-Marie Wills, MD, MPH, is a neurologist specializing in neurodegenerative disease, such as Parkinson's Disease, PSP, and ALS. She received her BA from Princeton University, her MD from Columbia College Physicians & Surgeons, and her MPH from Harvard School of Public Health. She completed her specialty training in the Partners Neurology residency program, a combined program between Massachusetts General Hospital and Brigham and Women's Hospital. She has been on staff at M.G.H. since 2006.
Dr. Wills' research focuses on environmental risk factors and determinants of neurodegenerative disease progression, including nutrition, caffeine and pesticides. Her multi-center clinical trial of nutrition in ALS (funded by the Muscular Dystrophy Association) showed that a calorically-dense diet was better tolerated and led to fewer adverse events, including deaths, than a standard diet (Wills et al. The Lancet, 2014). She is also investigating the effects of exercise interventions for neurodegenerative diseases.
She is the director of the CurePSP Center of Care at MGH which provides multidisciplinary care for people with Progressive Supranuclear Palsy. She is a member of the Movement Disorders Society, the Parkinson’s Study Group (PSG), the NorthEast ALS Consortium, and the American Academy of Neurology. She is co-director of the Genes and Environment Working Group of the PSG, co-founder of the Atypical Parkinsonian Disorders working group of the PSG and is the PI of several clinical trials in Parkinson’s disease and PSP.
Neuroscience Care at Mass General
Through a combination of unmatched expertise, creativity and compassion, Mass General Neuroscience relentlessly advances the fields of Neurosurgery, Neurology and Psychiatry to unleash our patients’ potential.